RALEIGH, N.C., Feb. 28, 2012 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. (OTCBB:INOLD.PK), a service based healthcare products development, integration and marketing company, announced today that it has received approval from the Financial Industry Regulatory Authority (“FINRA”) clearing the reverse stock split previously approved by its stockholders on September 14, 2011. According to FINRA’s approval, the reverse stock split took effect on Thursday, February 23, 2012 (“Effective Date”). On the Effective Date, the Company’s trading symbol was changed from “INOL” to “INOLD” for approximately 20 business days after which it will revert back to INOL. Upon the effectiveness of the reverse stock split, there will be approximately 4,897,313 shares issued and outstanding.
